Coronavirus rekindles age-old debate: Should human genes be patentable?

c gene patents x p nbcnews fp
Credit: Mladen Antonov/AFP

The sudden surge in the demand for a vaccine has seen the biotechnology industry rush to innovation and testing, which, if it results in any form of medications or vaccines, would likely lead to the filing of patent claims. These biotechnological advances heavily rely on human gene testing and its patentability. An age-old debate rekindles every time the issue of human gene patenting becomes a point of discussion and it inevitably ropes in the issues of human rights and the prevention of exploitation.

In cases like Diamond v. Chakrabarty and Myriad Insdustires, the [US Patent and Trademark Office] has generously argued that since human intervention is required to assimilate and understand the information that is stored and coded inside the proteins of DNA, it makes the attempt a ‘human intervention’ and hence renders the gene patentable, since it is isolated from the body. This stands in direct conflict with the patent laws of many developing regions like Brazil, India and Southeast Asia. 

Related article:  GMOs coming to Zimbabwe? Agriculture minister says climate change has made farm technology a necessity


It is absolutely possible for any legal decision or legal principle to be immoral even if it stays consistent with legal precedent. Human gene patenting is feared to exploit and exacerbate the inequality between the rich and the poor.

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend